Cleared Traditional

K170168 - Masimo Rad-97 and Accessories

K170168 is an FDA 510(k) clearance for Masimo Rad-97 and Accessories, manufactured by Masimo Corporation. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 238-day FDA review.

K170168 · Masimo Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
238d
Days
Class 2
Risk

K170168 is an FDA 510(k) clearance for the Masimo Rad-97 and Accessories. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Masimo Corporation (Irvine, US). The FDA issued a Cleared decision on September 14, 2017 after a review of 238 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Masimo Corporation devices

FDA 510(k) Submission Details - K170168

510(k) Number K170168 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2017
Decision Date September 14, 2017
Days to Decision 238 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 125d · This submission: 238d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 159
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K170168.
BETTERCARE PLATFORM - ADVANCED WEB CLIENT
K171361 · Better Care, S.L. · Feb 2018
WAVE Clinical Platform
K171056 · Excel Medical Electronics, LLC · Jan 2018
Masimo Root Monitoring System and Accessories
K171121 · Masimo Corporation · Nov 2017
Unity Network ID
K170199 · Ge Healthcare · May 2017
Truscope Ultra Patient Monitor
K162234 · Guangdong Biolight Meditech Co., Ltd. · Jan 2017
Vital Sync Informatics Manager & Virtual Patient Monitoring Platform
K160718 · Covidien · Nov 2016